nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalidixic Acid—TDO2—mammary gland—lung cancer	0.0257	0.627	CbGeAlD
Nalidixic Acid—TDO2—Tryptophan metabolism—HSD17B10—lung cancer	0.0202	0.147	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A18—lung cancer	0.0147	0.107	CbGpPWpGaD
Nalidixic Acid—TDO2—Amino acid and derivative metabolism—AZIN2—lung cancer	0.00945	0.0687	CbGpPWpGaD
Nalidixic Acid—TDO2—lung—lung cancer	0.00911	0.222	CbGeAlD
Nalidixic Acid—TDO2—Tryptophan metabolism—CYP2E1—lung cancer	0.00789	0.0574	CbGpPWpGaD
Nalidixic Acid—TDO2—Amino acid and derivative metabolism—HSD17B10—lung cancer	0.00655	0.0476	CbGpPWpGaD
Nalidixic Acid—TDO2—Tryptophan metabolism—CAT—lung cancer	0.00633	0.046	CbGpPWpGaD
Nalidixic Acid—TDO2—lymph node—lung cancer	0.00623	0.152	CbGeAlD
Nalidixic Acid—TDO2—Amino acid and derivative metabolism—CKB—lung cancer	0.00609	0.0443	CbGpPWpGaD
Nalidixic Acid—TDO2—Amino acid and derivative metabolism—CNDP2—lung cancer	0.00573	0.0416	CbGpPWpGaD
Nalidixic Acid—TDO2—Tryptophan metabolism—CYP1A1—lung cancer	0.00567	0.0412	CbGpPWpGaD
Nalidixic Acid—TDO2—Tryptophan metabolism—MDM2—lung cancer	0.0035	0.0254	CbGpPWpGaD
Nalidixic Acid—Norfloxacin—CYP2A6—lung cancer	0.00313	0.588	CrCbGaD
Nalidixic Acid—TDO2—Amino acid and derivative metabolism—GCLC—lung cancer	0.00301	0.0219	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A18—lung cancer	0.00295	0.0215	CbGpPWpGaD
Nalidixic Acid—TDO2—Amino acid and derivative metabolism—NQO1—lung cancer	0.00253	0.0184	CbGpPWpGaD
Nalidixic Acid—Neuropathy peripheral—Cisplatin—lung cancer	0.00241	0.00296	CcSEcCtD
Nalidixic Acid—Nausea—Gefitinib—lung cancer	0.00241	0.00295	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Topotecan—lung cancer	0.0024	0.00294	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Erlotinib—lung cancer	0.00238	0.00291	CcSEcCtD
Nalidixic Acid—Asthenia—Teniposide—lung cancer	0.00237	0.00291	CcSEcCtD
Nalidixic Acid—Angioedema—Vinorelbine—lung cancer	0.00235	0.00288	CcSEcCtD
Nalidixic Acid—Visual impairment—Irinotecan—lung cancer	0.00235	0.00288	CcSEcCtD
Nalidixic Acid—Pruritus—Teniposide—lung cancer	0.00234	0.00287	CcSEcCtD
Nalidixic Acid—Vertigo—Vinorelbine—lung cancer	0.00231	0.00283	CcSEcCtD
Nalidixic Acid—Leukopenia—Vinorelbine—lung cancer	0.0023	0.00282	CcSEcCtD
Nalidixic Acid—Paraesthesia—Vinblastine—lung cancer	0.00227	0.00278	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Paclitaxel—lung cancer	0.00227	0.00278	CcSEcCtD
Nalidixic Acid—Diarrhoea—Teniposide—lung cancer	0.00226	0.00277	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Gemcitabine—lung cancer	0.00224	0.00275	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Etoposide—lung cancer	0.00224	0.00274	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Topotecan—lung cancer	0.00223	0.00274	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Etoposide—lung cancer	0.00221	0.00271	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Erlotinib—lung cancer	0.00221	0.00271	CcSEcCtD
Nalidixic Acid—Paraesthesia—Topotecan—lung cancer	0.0022	0.0027	CcSEcCtD
Nalidixic Acid—Norfloxacin—CYP1A1—lung cancer	0.0022	0.412	CrCbGaD
Nalidixic Acid—Stevens-Johnson syndrome—Paclitaxel—lung cancer	0.00219	0.00269	CcSEcCtD
Nalidixic Acid—Arthralgia—Vinorelbine—lung cancer	0.00219	0.00268	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Paclitaxel—lung cancer	0.00217	0.00266	CcSEcCtD
Nalidixic Acid—Visual impairment—Cisplatin—lung cancer	0.00213	0.00261	CcSEcCtD
Nalidixic Acid—Vomiting—Teniposide—lung cancer	0.0021	0.00258	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Vinorelbine—lung cancer	0.0021	0.00257	CcSEcCtD
Nalidixic Acid—Rash—Teniposide—lung cancer	0.00209	0.00256	CcSEcCtD
Nalidixic Acid—Dermatitis—Teniposide—lung cancer	0.00208	0.00255	CcSEcCtD
Nalidixic Acid—Headache—Teniposide—lung cancer	0.00207	0.00254	CcSEcCtD
Nalidixic Acid—Erythema—Gemcitabine—lung cancer	0.00207	0.00253	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Vinblastine—lung cancer	0.00206	0.00253	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Vinorelbine—lung cancer	0.00205	0.00252	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Topotecan—lung cancer	0.00201	0.00246	CcSEcCtD
Nalidixic Acid—Abdominal pain—Vinblastine—lung cancer	0.002	0.00245	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Erlotinib—lung cancer	0.00198	0.00243	CcSEcCtD
Nalidixic Acid—Nausea—Teniposide—lung cancer	0.00197	0.00241	CcSEcCtD
Nalidixic Acid—Urticaria—Topotecan—lung cancer	0.00195	0.00239	CcSEcCtD
Nalidixic Acid—Abdominal pain—Topotecan—lung cancer	0.00194	0.00238	CcSEcCtD
Nalidixic Acid—Erythema—Cisplatin—lung cancer	0.00193	0.00236	CcSEcCtD
Nalidixic Acid—Abdominal pain—Erlotinib—lung cancer	0.00192	0.00235	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Etoposide—lung cancer	0.00192	0.00235	CcSEcCtD
Nalidixic Acid—Visual impairment—Paclitaxel—lung cancer	0.00191	0.00235	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Vinorelbine—lung cancer	0.00191	0.00234	CcSEcCtD
Nalidixic Acid—Vertigo—Irinotecan—lung cancer	0.0019	0.00233	CcSEcCtD
Nalidixic Acid—Leukopenia—Irinotecan—lung cancer	0.0019	0.00233	CcSEcCtD
Nalidixic Acid—Paraesthesia—Vinorelbine—lung cancer	0.00188	0.00231	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Paclitaxel—lung cancer	0.00188	0.0023	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Docetaxel—lung cancer	0.00186	0.00228	CcSEcCtD
Nalidixic Acid—Leukopenia—Gemcitabine—lung cancer	0.00185	0.00227	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Docetaxel—lung cancer	0.00184	0.00225	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Methotrexate—lung cancer	0.00181	0.00222	CcSEcCtD
Nalidixic Acid—Asthenia—Vinblastine—lung cancer	0.00181	0.00222	CcSEcCtD
Nalidixic Acid—SLC22A6—SLC-mediated transmembrane transport—SLC34A2—lung cancer	0.00177	0.0129	CbGpPWpGaD
Nalidixic Acid—Asthenia—Topotecan—lung cancer	0.00176	0.00216	CcSEcCtD
Nalidixic Acid—Arthralgia—Gemcitabine—lung cancer	0.00176	0.00215	CcSEcCtD
Nalidixic Acid—Asthenia—Erlotinib—lung cancer	0.00174	0.00213	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—COL4A3BP—lung cancer	0.00174	0.0126	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—AZIN2—lung cancer	0.00174	0.0126	CbGpPWpGaD
Nalidixic Acid—Pruritus—Topotecan—lung cancer	0.00174	0.00213	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Irinotecan—lung cancer	0.00173	0.00212	CcSEcCtD
Nalidixic Acid—Erythema—Paclitaxel—lung cancer	0.00173	0.00212	CcSEcCtD
Nalidixic Acid—Diarrhoea—Vinblastine—lung cancer	0.00173	0.00212	CcSEcCtD
Nalidixic Acid—Leukopenia—Cisplatin—lung cancer	0.00172	0.00211	CcSEcCtD
Nalidixic Acid—Pruritus—Erlotinib—lung cancer	0.00172	0.0021	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Vinorelbine—lung cancer	0.00172	0.0021	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Irinotecan—lung cancer	0.00169	0.00208	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Gemcitabine—lung cancer	0.00169	0.00207	CcSEcCtD
Nalidixic Acid—Diarrhoea—Topotecan—lung cancer	0.00168	0.00206	CcSEcCtD
Nalidixic Acid—Dizziness—Vinblastine—lung cancer	0.00167	0.00205	CcSEcCtD
Nalidixic Acid—Convulsion—Cisplatin—lung cancer	0.00167	0.00204	CcSEcCtD
Nalidixic Acid—Urticaria—Vinorelbine—lung cancer	0.00167	0.00204	CcSEcCtD
Nalidixic Acid—Diarrhoea—Erlotinib—lung cancer	0.00166	0.00203	CcSEcCtD
Nalidixic Acid—Abdominal pain—Vinorelbine—lung cancer	0.00166	0.00203	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Gemcitabine—lung cancer	0.00165	0.00202	CcSEcCtD
Nalidixic Acid—Visual impairment—Docetaxel—lung cancer	0.00162	0.00199	CcSEcCtD
Nalidixic Acid—Dizziness—Topotecan—lung cancer	0.00162	0.00199	CcSEcCtD
Nalidixic Acid—Vomiting—Vinblastine—lung cancer	0.00161	0.00197	CcSEcCtD
Nalidixic Acid—Dizziness—Erlotinib—lung cancer	0.0016	0.00197	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Docetaxel—lung cancer	0.00159	0.00195	CcSEcCtD
Nalidixic Acid—Dermatitis bullous—Doxorubicin—lung cancer	0.00159	0.00195	CcSEcCtD
Nalidixic Acid—Vertigo—Etoposide—lung cancer	0.00158	0.00194	CcSEcCtD
Nalidixic Acid—Headache—Vinblastine—lung cancer	0.00158	0.00194	CcSEcCtD
Nalidixic Acid—Angioedema—Paclitaxel—lung cancer	0.00158	0.00194	CcSEcCtD
Nalidixic Acid—Leukopenia—Etoposide—lung cancer	0.00158	0.00193	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Cisplatin—lung cancer	0.00157	0.00193	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Doxorubicin—lung cancer	0.00157	0.00192	CcSEcCtD
Nalidixic Acid—Vomiting—Topotecan—lung cancer	0.00156	0.00191	CcSEcCtD
Nalidixic Acid—Paraesthesia—Irinotecan—lung cancer	0.00155	0.0019	CcSEcCtD
Nalidixic Acid—Vertigo—Paclitaxel—lung cancer	0.00155	0.0019	CcSEcCtD
Nalidixic Acid—Leukopenia—Paclitaxel—lung cancer	0.00155	0.0019	CcSEcCtD
Nalidixic Acid—Rash—Topotecan—lung cancer	0.00155	0.00189	CcSEcCtD
Nalidixic Acid—Dermatitis—Topotecan—lung cancer	0.00155	0.00189	CcSEcCtD
Nalidixic Acid—Vomiting—Erlotinib—lung cancer	0.00154	0.00189	CcSEcCtD
Nalidixic Acid—Somnolence—Irinotecan—lung cancer	0.00154	0.00189	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Cisplatin—lung cancer	0.00154	0.00188	CcSEcCtD
Nalidixic Acid—Headache—Topotecan—lung cancer	0.00154	0.00188	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.00154	0.00188	CcSEcCtD
Nalidixic Acid—Rash—Erlotinib—lung cancer	0.00153	0.00187	CcSEcCtD
Nalidixic Acid—Dermatitis—Erlotinib—lung cancer	0.00153	0.00187	CcSEcCtD
Nalidixic Acid—Convulsion—Etoposide—lung cancer	0.00153	0.00187	CcSEcCtD
Nalidixic Acid—Headache—Erlotinib—lung cancer	0.00152	0.00186	CcSEcCtD
Nalidixic Acid—Diplopia—Doxorubicin—lung cancer	0.00152	0.00186	CcSEcCtD
Nalidixic Acid—Paraesthesia—Gemcitabine—lung cancer	0.00151	0.00185	CcSEcCtD
Nalidixic Acid—Asthenia—Vinorelbine—lung cancer	0.00151	0.00184	CcSEcCtD
Nalidixic Acid—Eosinophilia—Methotrexate—lung cancer	0.0015	0.00184	CcSEcCtD
Nalidixic Acid—Nausea—Vinblastine—lung cancer	0.0015	0.00184	CcSEcCtD
Nalidixic Acid—Somnolence—Gemcitabine—lung cancer	0.0015	0.00184	CcSEcCtD
Nalidixic Acid—Convulsion—Paclitaxel—lung cancer	0.0015	0.00184	CcSEcCtD
Nalidixic Acid—Pruritus—Vinorelbine—lung cancer	0.00148	0.00182	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—ATP5H—lung cancer	0.00148	0.0107	CbGpPWpGaD
Nalidixic Acid—Arthralgia—Paclitaxel—lung cancer	0.00147	0.0018	CcSEcCtD
Nalidixic Acid—Erythema—Docetaxel—lung cancer	0.00147	0.0018	CcSEcCtD
Nalidixic Acid—Nausea—Topotecan—lung cancer	0.00146	0.00179	CcSEcCtD
Nalidixic Acid—Nausea—Erlotinib—lung cancer	0.00144	0.00177	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Etoposide—lung cancer	0.00144	0.00176	CcSEcCtD
Nalidixic Acid—Diarrhoea—Vinorelbine—lung cancer	0.00144	0.00176	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Cisplatin—lung cancer	0.00143	0.00175	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Irinotecan—lung cancer	0.00141	0.00173	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Paclitaxel—lung cancer	0.00141	0.00173	CcSEcCtD
Nalidixic Acid—Paraesthesia—Cisplatin—lung cancer	0.00141	0.00173	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Etoposide—lung cancer	0.00141	0.00173	CcSEcCtD
Nalidixic Acid—Dizziness—Vinorelbine—lung cancer	0.00139	0.0017	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Methotrexate—lung cancer	0.00138	0.0017	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Paclitaxel—lung cancer	0.00138	0.00169	CcSEcCtD
Nalidixic Acid—Abdominal pain—Irinotecan—lung cancer	0.00137	0.00168	CcSEcCtD
Nalidixic Acid—Drowsiness—Methotrexate—lung cancer	0.00135	0.00166	CcSEcCtD
Nalidixic Acid—SLC22A6—SLC-mediated transmembrane transport—SLC22A18—lung cancer	0.00134	0.00976	CbGpPWpGaD
Nalidixic Acid—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.00134	0.00164	CcSEcCtD
Nalidixic Acid—Vomiting—Vinorelbine—lung cancer	0.00133	0.00163	CcSEcCtD
Nalidixic Acid—Rash—Vinorelbine—lung cancer	0.00132	0.00162	CcSEcCtD
Nalidixic Acid—Dermatitis—Vinorelbine—lung cancer	0.00132	0.00162	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—PLBD1—lung cancer	0.00132	0.00957	CbGpPWpGaD
Nalidixic Acid—Headache—Vinorelbine—lung cancer	0.00131	0.00161	CcSEcCtD
Nalidixic Acid—Leukopenia—Docetaxel—lung cancer	0.00131	0.00161	CcSEcCtD
Nalidixic Acid—Eosinophilia—Doxorubicin—lung cancer	0.0013	0.00159	CcSEcCtD
Nalidixic Acid—Paraesthesia—Etoposide—lung cancer	0.00129	0.00158	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.00129	0.00158	CcSEcCtD
Nalidixic Acid—Somnolence—Etoposide—lung cancer	0.00128	0.00157	CcSEcCtD
Nalidixic Acid—Convulsion—Docetaxel—lung cancer	0.00127	0.00156	CcSEcCtD
Nalidixic Acid—Paraesthesia—Paclitaxel—lung cancer	0.00127	0.00155	CcSEcCtD
Nalidixic Acid—Somnolence—Paclitaxel—lung cancer	0.00125	0.00154	CcSEcCtD
Nalidixic Acid—Arthralgia—Docetaxel—lung cancer	0.00125	0.00153	CcSEcCtD
Nalidixic Acid—Nausea—Vinorelbine—lung cancer	0.00125	0.00153	CcSEcCtD
Nalidixic Acid—Asthenia—Irinotecan—lung cancer	0.00124	0.00152	CcSEcCtD
Nalidixic Acid—Asthenia—Gemcitabine—lung cancer	0.00121	0.00148	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—HSD17B10—lung cancer	0.0012	0.00875	CbGpPWpGaD
Nalidixic Acid—Photosensitivity reaction—Doxorubicin—lung cancer	0.0012	0.00147	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Docetaxel—lung cancer	0.0012	0.00147	CcSEcCtD
Nalidixic Acid—Pruritus—Gemcitabine—lung cancer	0.00119	0.00146	CcSEcCtD
Nalidixic Acid—Diarrhoea—Irinotecan—lung cancer	0.00118	0.00145	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Etoposide—lung cancer	0.00118	0.00144	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Docetaxel—lung cancer	0.00117	0.00144	CcSEcCtD
Nalidixic Acid—Drowsiness—Doxorubicin—lung cancer	0.00117	0.00143	CcSEcCtD
Nalidixic Acid—Visual impairment—Methotrexate—lung cancer	0.00117	0.00143	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.00116	0.00142	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Paclitaxel—lung cancer	0.00115	0.00141	CcSEcCtD
Nalidixic Acid—Diarrhoea—Gemcitabine—lung cancer	0.00115	0.00141	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Methotrexate—lung cancer	0.00115	0.00141	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Doxorubicin—lung cancer	0.00115	0.00141	CcSEcCtD
Nalidixic Acid—Dizziness—Irinotecan—lung cancer	0.00114	0.0014	CcSEcCtD
Nalidixic Acid—Urticaria—Etoposide—lung cancer	0.00114	0.0014	CcSEcCtD
Nalidixic Acid—Abdominal pain—Etoposide—lung cancer	0.00114	0.00139	CcSEcCtD
Nalidixic Acid—Asthenia—Cisplatin—lung cancer	0.00113	0.00138	CcSEcCtD
Nalidixic Acid—Urticaria—Paclitaxel—lung cancer	0.00112	0.00137	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—CKB—lung cancer	0.00112	0.00813	CbGpPWpGaD
Nalidixic Acid—Abdominal pain—Paclitaxel—lung cancer	0.00112	0.00137	CcSEcCtD
Nalidixic Acid—Vomiting—Irinotecan—lung cancer	0.0011	0.00135	CcSEcCtD
Nalidixic Acid—Rash—Irinotecan—lung cancer	0.00109	0.00134	CcSEcCtD
Nalidixic Acid—Dermatitis—Irinotecan—lung cancer	0.00109	0.00134	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Docetaxel—lung cancer	0.00109	0.00134	CcSEcCtD
Nalidixic Acid—Headache—Irinotecan—lung cancer	0.00108	0.00133	CcSEcCtD
Nalidixic Acid—Diarrhoea—Cisplatin—lung cancer	0.00107	0.00132	CcSEcCtD
Nalidixic Acid—Paraesthesia—Docetaxel—lung cancer	0.00107	0.00132	CcSEcCtD
Nalidixic Acid—Vomiting—Gemcitabine—lung cancer	0.00107	0.00131	CcSEcCtD
Nalidixic Acid—Somnolence—Docetaxel—lung cancer	0.00106	0.0013	CcSEcCtD
Nalidixic Acid—Rash—Gemcitabine—lung cancer	0.00106	0.0013	CcSEcCtD
Nalidixic Acid—Dermatitis—Gemcitabine—lung cancer	0.00106	0.0013	CcSEcCtD
Nalidixic Acid—Erythema—Methotrexate—lung cancer	0.00106	0.00129	CcSEcCtD
Nalidixic Acid—Headache—Gemcitabine—lung cancer	0.00106	0.00129	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—CNDP2—lung cancer	0.00105	0.00765	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—GSTM2—lung cancer	0.00105	0.00765	CbGpPWpGaD
Nalidixic Acid—Asthenia—Etoposide—lung cancer	0.00103	0.00127	CcSEcCtD
Nalidixic Acid—Nausea—Irinotecan—lung cancer	0.00103	0.00126	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—MTMR3—lung cancer	0.00102	0.00744	CbGpPWpGaD
Nalidixic Acid—Pruritus—Etoposide—lung cancer	0.00102	0.00125	CcSEcCtD
Nalidixic Acid—Visual impairment—Doxorubicin—lung cancer	0.00101	0.00124	CcSEcCtD
Nalidixic Acid—Asthenia—Paclitaxel—lung cancer	0.00101	0.00124	CcSEcCtD
Nalidixic Acid—Nausea—Gemcitabine—lung cancer	0.001	0.00123	CcSEcCtD
Nalidixic Acid—Vomiting—Cisplatin—lung cancer	0.000999	0.00122	CcSEcCtD
Nalidixic Acid—Pruritus—Paclitaxel—lung cancer	0.000998	0.00122	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—PGAM1—lung cancer	0.000997	0.00725	CbGpPWpGaD
Nalidixic Acid—Erythema multiforme—Doxorubicin—lung cancer	0.000994	0.00122	CcSEcCtD
Nalidixic Acid—Rash—Cisplatin—lung cancer	0.000991	0.00121	CcSEcCtD
Nalidixic Acid—Dermatitis—Cisplatin—lung cancer	0.00099	0.00121	CcSEcCtD
Nalidixic Acid—Diarrhoea—Etoposide—lung cancer	0.000985	0.00121	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Docetaxel—lung cancer	0.000978	0.0012	CcSEcCtD
Nalidixic Acid—Diarrhoea—Paclitaxel—lung cancer	0.000966	0.00118	CcSEcCtD
Nalidixic Acid—Dizziness—Etoposide—lung cancer	0.000952	0.00117	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—CYP2A7—lung cancer	0.000951	0.00692	CbGpPWpGaD
Nalidixic Acid—Vertigo—Methotrexate—lung cancer	0.000949	0.00116	CcSEcCtD
Nalidixic Acid—Abdominal pain—Docetaxel—lung cancer	0.000946	0.00116	CcSEcCtD
Nalidixic Acid—Leukopenia—Methotrexate—lung cancer	0.000946	0.00116	CcSEcCtD
Nalidixic Acid—Dizziness—Paclitaxel—lung cancer	0.000933	0.00114	CcSEcCtD
Nalidixic Acid—Nausea—Cisplatin—lung cancer	0.000933	0.00114	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—SDC4—lung cancer	0.000931	0.00677	CbGpPWpGaD
Nalidixic Acid—Convulsion—Methotrexate—lung cancer	0.000915	0.00112	CcSEcCtD
Nalidixic Acid—Vomiting—Etoposide—lung cancer	0.000915	0.00112	CcSEcCtD
Nalidixic Acid—Erythema—Doxorubicin—lung cancer	0.000915	0.00112	CcSEcCtD
Nalidixic Acid—Rash—Etoposide—lung cancer	0.000908	0.00111	CcSEcCtD
Nalidixic Acid—Dermatitis—Etoposide—lung cancer	0.000907	0.00111	CcSEcCtD
Nalidixic Acid—Headache—Etoposide—lung cancer	0.000902	0.0011	CcSEcCtD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.0009	0.00655	CbGpPWpGaD
Nalidixic Acid—Arthralgia—Methotrexate—lung cancer	0.000899	0.0011	CcSEcCtD
Nalidixic Acid—Vomiting—Paclitaxel—lung cancer	0.000897	0.0011	CcSEcCtD
Nalidixic Acid—Rash—Paclitaxel—lung cancer	0.00089	0.00109	CcSEcCtD
Nalidixic Acid—Dermatitis—Paclitaxel—lung cancer	0.000889	0.00109	CcSEcCtD
Nalidixic Acid—Headache—Paclitaxel—lung cancer	0.000884	0.00108	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Methotrexate—lung cancer	0.000862	0.00106	CcSEcCtD
Nalidixic Acid—Asthenia—Docetaxel—lung cancer	0.000858	0.00105	CcSEcCtD
Nalidixic Acid—Nausea—Etoposide—lung cancer	0.000855	0.00105	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—RRM1—lung cancer	0.000848	0.00616	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—GSTA3—lung cancer	0.000848	0.00616	CbGpPWpGaD
Nalidixic Acid—Pruritus—Docetaxel—lung cancer	0.000846	0.00104	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Methotrexate—lung cancer	0.000844	0.00103	CcSEcCtD
Nalidixic Acid—Nausea—Paclitaxel—lung cancer	0.000838	0.00103	CcSEcCtD
Nalidixic Acid—Vertigo—Doxorubicin—lung cancer	0.000822	0.00101	CcSEcCtD
Nalidixic Acid—Leukopenia—Doxorubicin—lung cancer	0.000819	0.001	CcSEcCtD
Nalidixic Acid—Diarrhoea—Docetaxel—lung cancer	0.000818	0.001	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—B4GALT5—lung cancer	0.000797	0.0058	CbGpPWpGaD
Nalidixic Acid—Convulsion—Doxorubicin—lung cancer	0.000793	0.000971	CcSEcCtD
Nalidixic Acid—Dizziness—Docetaxel—lung cancer	0.000791	0.000969	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000785	0.000962	CcSEcCtD
Nalidixic Acid—Arthralgia—Doxorubicin—lung cancer	0.000779	0.000954	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—GSTA4—lung cancer	0.000775	0.00564	CbGpPWpGaD
Nalidixic Acid—Paraesthesia—Methotrexate—lung cancer	0.000774	0.000949	CcSEcCtD
Nalidixic Acid—Somnolence—Methotrexate—lung cancer	0.000766	0.000939	CcSEcCtD
Nalidixic Acid—Vomiting—Docetaxel—lung cancer	0.000761	0.000932	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—GSTA2—lung cancer	0.000755	0.00549	CbGpPWpGaD
Nalidixic Acid—Rash—Docetaxel—lung cancer	0.000754	0.000924	CcSEcCtD
Nalidixic Acid—Dermatitis—Docetaxel—lung cancer	0.000754	0.000923	CcSEcCtD
Nalidixic Acid—Headache—Docetaxel—lung cancer	0.000749	0.000918	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Doxorubicin—lung cancer	0.000747	0.000915	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Doxorubicin—lung cancer	0.000731	0.000896	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—GSTA1—lung cancer	0.000729	0.0053	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—ABCC3—lung cancer	0.000721	0.00524	CbGpPWpGaD
Nalidixic Acid—Nausea—Docetaxel—lung cancer	0.000711	0.000871	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Methotrexate—lung cancer	0.000705	0.000864	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—AKR1C1—lung cancer	0.000698	0.00508	CbGpPWpGaD
Nalidixic Acid—Urticaria—Methotrexate—lung cancer	0.000685	0.000839	CcSEcCtD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.000682	0.00496	CbGpPWpGaD
Nalidixic Acid—Abdominal pain—Methotrexate—lung cancer	0.000682	0.000835	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.00068	0.000833	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—UGT1A1—lung cancer	0.000678	0.00493	CbGpPWpGaD
Nalidixic Acid—Paraesthesia—Doxorubicin—lung cancer	0.00067	0.000821	CcSEcCtD
Nalidixic Acid—Somnolence—Doxorubicin—lung cancer	0.000664	0.000813	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—GNG11—lung cancer	0.000653	0.00475	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—ALDOA—lung cancer	0.000622	0.00452	CbGpPWpGaD
Nalidixic Acid—Asthenia—Methotrexate—lung cancer	0.000619	0.000758	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Doxorubicin—lung cancer	0.00061	0.000748	CcSEcCtD
Nalidixic Acid—Pruritus—Methotrexate—lung cancer	0.00061	0.000747	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—NCOA3—lung cancer	0.000604	0.00439	CbGpPWpGaD
Nalidixic Acid—Urticaria—Doxorubicin—lung cancer	0.000593	0.000727	CcSEcCtD
Nalidixic Acid—Abdominal pain—Doxorubicin—lung cancer	0.00059	0.000723	CcSEcCtD
Nalidixic Acid—Diarrhoea—Methotrexate—lung cancer	0.00059	0.000723	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—ADCY1—lung cancer	0.000588	0.00427	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—ABCG2—lung cancer	0.000588	0.00427	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—ENO2—lung cancer	0.000576	0.00419	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—HPGDS—lung cancer	0.000576	0.00419	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PPP2R1B—lung cancer	0.000573	0.00416	CbGpPWpGaD
Nalidixic Acid—Dizziness—Methotrexate—lung cancer	0.00057	0.000699	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—GSTT1—lung cancer	0.000559	0.00406	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—GCLC—lung cancer	0.000552	0.00402	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—CYP2A6—lung cancer	0.000552	0.00402	CbGpPWpGaD
Nalidixic Acid—Vomiting—Methotrexate—lung cancer	0.000548	0.000672	CcSEcCtD
Nalidixic Acid—Rash—Methotrexate—lung cancer	0.000544	0.000666	CcSEcCtD
Nalidixic Acid—Dermatitis—Methotrexate—lung cancer	0.000543	0.000665	CcSEcCtD
Nalidixic Acid—Headache—Methotrexate—lung cancer	0.00054	0.000662	CcSEcCtD
Nalidixic Acid—Asthenia—Doxorubicin—lung cancer	0.000536	0.000656	CcSEcCtD
Nalidixic Acid—Pruritus—Doxorubicin—lung cancer	0.000528	0.000647	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—ENO1—lung cancer	0.000524	0.00381	CbGpPWpGaD
Nalidixic Acid—Nausea—Methotrexate—lung cancer	0.000512	0.000628	CcSEcCtD
Nalidixic Acid—Diarrhoea—Doxorubicin—lung cancer	0.000511	0.000626	CcSEcCtD
Nalidixic Acid—Dizziness—Doxorubicin—lung cancer	0.000494	0.000605	CcSEcCtD
Nalidixic Acid—Vomiting—Doxorubicin—lung cancer	0.000475	0.000582	CcSEcCtD
Nalidixic Acid—Rash—Doxorubicin—lung cancer	0.000471	0.000577	CcSEcCtD
Nalidixic Acid—Dermatitis—Doxorubicin—lung cancer	0.00047	0.000576	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—CYP2E1—lung cancer	0.00047	0.00342	CbGpPWpGaD
Nalidixic Acid—Headache—Doxorubicin—lung cancer	0.000468	0.000573	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—NQO1—lung cancer	0.000464	0.00338	CbGpPWpGaD
Nalidixic Acid—Nausea—Doxorubicin—lung cancer	0.000443	0.000543	CcSEcCtD
Nalidixic Acid—SLC22A6—SLC-mediated transmembrane transport—AVP—lung cancer	0.000423	0.00307	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—STK11—lung cancer	0.000419	0.00304	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000409	0.00297	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—GSTP1—lung cancer	0.000387	0.00282	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—CAT—lung cancer	0.000377	0.00274	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—GNG11—lung cancer	0.000371	0.00269	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—ABCB1—lung cancer	0.000367	0.00267	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—TYMS—lung cancer	0.00036	0.00262	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—GSTM1—lung cancer	0.000356	0.00259	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—CYP1A1—lung cancer	0.000337	0.00245	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—ERCC2—lung cancer	0.000335	0.00243	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000333	0.00242	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000333	0.00242	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—TF—lung cancer	0.00031	0.00225	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—APOA1—lung cancer	0.00029	0.00211	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PIK3CG—lung cancer	0.000264	0.00192	CbGpPWpGaD
Nalidixic Acid—SLC22A6—SLC-mediated transmembrane transport—ALB—lung cancer	0.000256	0.00186	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—POMC—lung cancer	0.000252	0.00183	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—CREBBP—lung cancer	0.000245	0.00178	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PIK3CD—lung cancer	0.000232	0.00169	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—ALB—lung cancer	0.000229	0.00167	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—AVP—lung cancer	0.000215	0.00156	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—ABCB1—lung cancer	0.000208	0.00151	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PIK3CB—lung cancer	0.000203	0.00147	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PTGS2—lung cancer	0.000201	0.00146	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PTEN—lung cancer	0.000175	0.00127	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—EP300—lung cancer	0.000167	0.00121	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—APOA1—lung cancer	0.000164	0.00119	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—CREBBP—lung cancer	0.000139	0.00101	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—ALB—lung cancer	0.00013	0.000946	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PIK3CA—lung cancer	0.000123	0.000898	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—RAF1—lung cancer	0.000118	0.000856	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—AKT1—lung cancer	0.000101	0.000733	CbGpPWpGaD
